3-Trifluoromethyl-4-chlorophenylpiperazine (TFMCPP; code name PAL-179), or meta-trifluoromethyl-para-chlorophenylpiperazine, is a monoamine releasing agent of the phenylpiperazine family. It acts specifically as a selective partial serotonin releasing agent, with an of 33nM and an of 66%. The drug was inactive as a releasing agent of dopamine or norepinephrine ( >10,000nM). Its possible activity at serotonin receptors was not reported. TFMCPP was first described in the scientific literature by 2012.